4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...
GlobalData on MSN
Japan’s MHLW grants orphan status to Kyowa and Orchard’s MLD therapy
Japan's Ministry of Health, Labor and Welfare (MHLW) has granted orphan regenerative medicine product designation to Kyowa ...
– Kite Cell Therapy Business Unit at Gilead Sciences K.K. Will Manage the Sales and Promotion Activities in Japan After the Marketing Authorization Transfer – SANTA MONICA, Calif. & TOKYO--(BUSINESS ...
Stempeutics India and MEDINET Japan have announced an option license agreement for Stempeucel, a cell therapy product for treating CLTI in Japan. This deal could lead to an exclusive license, allowing ...
Stempeutics partners with Japan's Medinet to license Stempeucel for treating chronic limb threatening ischemia, marking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback